International journal of clinical and experimental medicine
-
Combined use of memantine and acetylcholinesterase inhibitors (AChEIs) has shown improved outcomes in patients with Alzheimer's disease (AD). However, it is not clear which AChEI is the optimal for the combined treatment with memantine. ⋯ Huperzine A may be an optimal choice for the combined therapy with memantine in treating AD.